Alloplex’s Dr. Frank Borriello will be highlighting the differentiation of the Alloplex oncology therapy at Roth’s Capital Partners’ Virtual Healthcare Private Company Forum on June 28, 2021. He is participating in Cancer Panel 2, entitled ‘Natural Killer Cell Approaches to Eradicate Tumors’, which will be hosted by Roth’s Capital Partners’ analyst Tony Butler, PhD.